Bertani L, Ribaldone DG, Bossa F, Guerra M, et al. Response to Letter to the Editor: "Enhancing the robustness of early vs late switch to subcutaneous infliximab in inflammatory bowel disease (IBD): the value of propensity score analysis". Inflamm Bowel Dis 2026 Mar 14:izag034. doi: 10.1093.
PMID: 41830955